06 July 2018

In the first quarter of this year, our API Plant was visited by the Polish Authorities (MPI, Main Pharmaceutical Inspectorate). The Agency plays a key role in coordinating and harmonising GMP activities at an EU level.

The inspection was carried out from 27/02 to 1/03/2018 and finished with a positive result! The inspectors will recommend the issue of GMP certificates for all the substances evaluated, included in the list below. This was a further acknowledgment that Polpharma is your European B2B Partner and meets GMP requirements.

Our worldwide quality enables us to be present in over 60 countries.

The certificate was issued for our below active pharmaceutical ingredients:

  • Empagliflozin
  • Ethenzamide
  • Linagliptin
  • Salicylamide
  • Sacubitril/ Valsartan complex
  • Phenyl salicylate
  • Sodium salicylate

Talk with our Sales Team!

Read more